Evidence map›Paper›PMID 29740251›Full record

ArticleSaudi journal of biological sciences2018

Inhibition of EGF expression and NF-κB activity by treatment with quercetin leads to suppression of angiogenesis in nasopharyngeal carcinoma.

Dong-Yan Huang, Zhi-Rao Dai, Wei-Min Li, Rong-Guan Wang, Shi-Ming Yang

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Flavonoids with Anti-Angiogenesis Function in Cancer.Molecules (Basel, Switzerland) · 2024
    Review
  5. Review
  6. Article
  7. Article
  8. Luteolin Isolated fromBioMed research international · 2022
    Article
  9. Review
  10. Analysis of the Molecular Mechanism ofJournal of healthcare engineering · 2022
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dong-Yan HuangDepartment of Otolaryngology-Head and Neck Surgery, Clinical Division of Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Zhi-Rao DaiDepartment of Otolaryngology, The First Affiliated Hospital of PLA General Hospital, Beijing 100853, China.
Wei-Min LiDepartment of Otolaryngology-Head and Neck Surgery, Clinical Division of Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Rong-Guan WangDepartment of Otolaryngology-Head and Neck Surgery, Clinical Division of Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Shi-Ming YangDepartment of Otolaryngology-Head and Neck Surgery, Clinical Division of Surgery, Chinese PLA General Hospital, Beijing 100853, China.
Chinese PLA General Hospital · CNFirst Affiliated Hospital of Chinese PLA General Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The present study was performed to investigate the effect of quercetin on nasopharyngeal carcinoma (NPC) angiogenesis. The real-time RT-PCR and enzyme-linked immunosorbent assays (ELISA) were performed to analyze the expression levels of vascular endothelial growth factor (VEGF) in nasopharyngeal carcinoma cell lines prior to and after the quercetin treatment. Effect of quercetin on the rate of cell proliferation was measured by MTT assay. It was observed that quercetin treatment at a concentration of 10 mg/mL reduced the rate of NPC039 cell viability to 36% compared to control after 24 h. The expression of VEGF and activity of NF-κB was also markedly reduced. The ability of tube formation in HUVECs was inhibited significantly on exposure to quercetin compared to the untreated cells. Therefore, quercetin plays an important role in the inhibition of NPC039 nasopharyngeal carcinoma and can be of therapeutic importance.

Indexed as

InhibitionNasopharyngeal carcinomaQuercetinVEGFViability

Identifiers

PMID29740251
PMCPMC5936869
OpenAlexW2555801180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.